PHASE I RESULTS FROM RTOG 0929, A RANDOMIZED PHASE I/II STUDY OF ABT-888 (VELIPARIB) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN RECURRENT, TMZ-RESISTANT GLIOBLASTOMA Conference

Robins, HI, Wang, Meihua, Gilbert, Mark R et al. (2012). PHASE I RESULTS FROM RTOG 0929, A RANDOMIZED PHASE I/II STUDY OF ABT-888 (VELIPARIB) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN RECURRENT, TMZ-RESISTANT GLIOBLASTOMA . NEURO-ONCOLOGY, 14 67-67.

cited authors

  • Robins, HI; Wang, Meihua; Gilbert, Mark R; Chakravarti, Arnab; Grimm, Sean; Penas-Prado, Martya; Chaudhary, Rekha; Anderson, Paul J; Elinzano, Heinrich; Gilbert, Robert A; Mehta, Minesh

sustainable development goals

authors

date/time interval

  • November 15, 2012 -

publication date

  • October 1, 2012

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • Washington, DC

Conference

  • 17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 67

end page

  • 67

volume

  • 14